| Literature DB >> 25356301 |
Ege Can Serefoglu1, Chris G McMahon2, Marcel D Waldinger3, Stanley E Althof4, Alan Shindel5, Ganesh Adaikan6, Edgardo F Becher7, John Dean8, Francois Giuliano9, Wayne Jg Hellstrom10, Annamaria Giraldi11, Sidney Glina12, Luca Incrocci13, Emmanuele Jannini14, Marita McCabe15, Sharon Parish16, David Rowland17, R Taylor Segraves18, Ira Sharlip19, Luiz Otavio Torres20.
Abstract
INTRODUCTION: The International Society for Sexual Medicine (ISSM) Ad Hoc Committee for the Definition of Premature Ejaculation developed the first evidence-based definition for lifelong premature ejaculation (PE) in 2007 and concluded that there were insufficient published objective data at that time to develop a definition for acquired PE. AIM: The aim of this article is to review and critique the current literature and develop a contemporary, evidence-based definition for acquired PE and/or a unified definition for both lifelong and acquired PE.Entities:
Keywords: Acquired Premature Ejaculation; Definition; Ejaculatory Control; Interpersonal Distress; Intravaginal Ejaculatory Latency Time; Lifelong Premature Ejaculation; Negative Personal Psychological Consequences; Personal Distress; Premature Ejaculation; Sexual Satisfaction
Year: 2014 PMID: 25356301 PMCID: PMC4184676 DOI: 10.1002/sm2.27
Source DB: PubMed Journal: Sex Med ISSN: 2050-1161 Impact factor: 2.491
Findings of key publications regarding time to ejaculation in PE
| Study | Summary of primary findings |
|---|---|
| Waldinger et al. 1998 [ | • 110 men with lifelong PE whose IELT was measured by the use of a stopwatch |
| • 40% of men ejaculated within 15 seconds, 70% within 30 seconds, and 90% within 1 minute | |
| McMahon 2002 [ | • 1,346 consecutive men with PE whose IELT was measured by the use of a stopwatch/wristwatch |
| • 77% of men ejaculated within 1 minute | |
| Waldinger et al. 2007 [ | • 88 men with lifelong PE who self-estimated IELT |
| • 30% of men ejaculated within 15 seconds, 67% within 30 seconds, and 92% within 1 minute after penetration | |
| • Only 5% ejaculated between 1 and 2 minutes | |
| Waldinger et al. 2005 [ | • Stopwatch IELT study in a random unselected group of 491 men in 5 countries |
| • IELT had a positively skewed distribution | |
| • Application of 0.5 and 2.5 percentiles as disease standards; 0.5 percentile equated to an IELT of 0.9 minutes and 2.5 percentile to an IELT of 1.3 minutes | |
| Althof 1995 [ | • IELT estimations for PE men correlate reasonably well with stopwatch-recorded IELT |
| Pryor et al. 2005 [ | • IELT estimations for PE men correlate reasonably well with stopwatch-recorded IELT |
| Rosen et al. 2007 [ | • Self estimated and stopwatch IELT as interchangeable |
| • Combining self-estimated IELT and PROs reliably predicts PE | |
| Porst et al. 2010 [ | • Stopwatch IELT was slightly (but significantly) greater for patients with acquired PE vs. lifelong PE (0.9 vs. 0.7 minutes, |
| McMahon et al. 2013 [ | • Stopwatch IELT was significantly greater for patients with acquired PE vs. lifelong PE (0.9 vs. 0.7 minutes, |
| Serefoglu et al. 2010 [ | • Self-estimated IELT was lowest in men with lifelong PE and highest in men with subjective PE |
| • Lifelong PE: 20.47 ± 28.90 seconds (2–120 seconds); acquired PE: 57.91 ± 38.72 seconds (90–180 seconds); variable PE: 144.17 ± 22.47 seconds (120–180 seconds); subjective PE: 286.67 ± 69.96 seconds (180–420 seconds); | |
| Zhang et al. 2013 [ | • Self-estimated IELT follows a continuum among the four PE syndromes |
| • Mean self-estimated IELT of 1.65 ± 0.82 minutes in acquired PE patients | |
| Gao et al. 2013 [ | • Self-estimated IELT follows a continuum among the four PE syndromes |
| • Mean self-estimated IELT of 1.84 ± 1.02 minutes in acquired PE patients |
Findings of key publications regarding ejaculatory control in PE
| Study | Summary of primary findings |
|---|---|
| Grenier and Byers 1997 [ | • Relatively weak correlation between ejaculatory latency and ejaculatory control ( |
| • Ejaculatory control and latency are distinct concepts | |
| Grenier and Byers 2001 [ | • Relatively poor correlation between ejaculatory latency and ejaculatory control, sharing only 12% of their variance, suggesting that these PROs are relatively independent |
| Waldinger et al. 1998 [ | • Little or no control over ejaculation was reported by 98% of subjects during intercourse |
| • Weak correlation between ejaculatory control and stopwatch IELT ( | |
| Rowland et al. 2000 [ | • High correlation between measures of ejaculatory latency and control ( |
| Patrick et al. 2005 [ | • Men diagnosed with PE had significantly lower mean ratings of control over ejaculation ( |
| • 72% of men with PE reported ratings of “very poor” or “poor” for control over ejaculation, compared with 5% in a group of normal controls | |
| • IELT was strongly positively correlated with control over ejaculation for subjects ( | |
| Giuliano et al. 2007 [ | • Men diagnosed with PE had significantly lower mean ratings of control over ejaculation ( |
| • “Good” or “very good” control over ejaculation in only 13.2% of PE subjects compared to 78.4% of non-PE subjects | |
| • Perceived control over ejaculation had a significant effect on intercourse satisfaction and personal distress | |
| • IELT did not have a direct effect on intercourse satisfaction and had only a small direct effect on personal distress | |
| Patrick et al. 2007 [ | • Effect of IELT upon satisfaction and distress appears to be mediated via its direct effect upon control |
| Rosen et al. 2007 [ | • Control over ejaculation and subject-assessed level of personal distress are more influential in determining PE status than IELT |
| • Subject reporting “very good” or “good” control over ejaculation is 90.6% less likely to have PE than a subject reporting “poor” or “very poor” control over ejaculation |
Findings of key publications regarding the negative personal consequences of PE
| Study | Summary of primary findings |
|---|---|
| Patrick et al. 2005 [ | • Using the validated Premature Ejaculation Profile, 64% of men in the PE group vs. 4% in the non-PE group reported personal distress |
| Giuliano et al. 2007 [ | • On the Premature Ejaculation Profile, 44% of men in the PE group vs. 1% of men in non-PE group reported personal distress |
| Rowland et al. 2007 [ | • Men in highly probable PE group reported greater distress vs. men in non-PE group on Premature Ejaculation Profile scale |
| • On the Self-Esteem and Relationship Questionnaire, men with highly probable PE had lower mean scores overall for confidence and self-esteem vs. non PE men | |
| Rowland et al. 2004 [ | • 30.7% of probable PE group, 16.4% of possible PE group, 7.7% of non-PE group found it difficult to relax and not be anxious about intercourse |
| Porst et al. 2007 [ | • Depression reported by 20.4% of PE group vs. 12.4% of non-PE group |
| • Excessive stress in 28% of PE group vs. 19% of non-PE group | |
| • Anxiety in 24% of PE group vs. 13% of non-PE group | |
| McCabe 1997 [ | • Sexually dysfunctional men, including those with PE, scored lower than sexually functional men on all measures of intimacy on the Psychological and Interpersonal Relationship Scale |
| Symonds et al. 2003 [ | • 68% reported self-esteem affected by PE; decreased confidence during sexual encounters |
| • Anxiety reported by 36% (causing PE or because of it) | |
| • Embarrassment and depression also cited as due to PE | |
| Dunn et al. 1999 [ | Strong association of PE with anxiety and depression on the Hospital Depression and Anxiety Scales |
| Hartmann et al. 2005 [ | 58% of PE group reported partner's behavior and reaction to PE was positive, and 23% reported it was negative |
| Byers et al. 2003 [ | Men with PE and their partners reported slightly negative impact of PE on personal functioning and sexual relationship but no negative impact on overall relationship |
Findings of key publications on the prevalence of premature ejaculation
| Study | Method of data collection | Method of sample recruitment | Specific operational criteria | Prevalence rate | Number of men |
|---|---|---|---|---|---|
| Dunn et al. 1998 [ | General practice registers—random stratification | Having difficulty with ejaculating prematurely | 14% (past 3 months) | 617 | |
| 31% (lifetime) | 618 | ||||
| Laumann et al. 1999 (National Health and Social Life Survey) [ | Interview | NA | Climaxing/ ejaculating too rapidly during the past 12 months | 31% | 1,410 |
| Fugl-Meyer et al. 2002 [ | Interview | Population register | NA | 9% | 1,475 |
| Rowland et al. 2004 [ | Mailed questionnaire | Internet panel | DSM-IV | 16.3% | 1,158 |
| Nolazco et al. 2004 [ | Interview | Invitation to outpatient clinic | Ejaculating fast or prematurely | 28.3% | 2,456 |
| Laumann et al. 2005 (Global Study of Sexual Attitudes and Behaviors) [ | Telephone-personal interview/mailed questionnaires | Random (systematic) sampling | Reaching climax too quickly during the past 12 months | 23.75% (4.26% frequently) | 13,618 |
| Fasolo et al. 2005 [ | Clinician-based | Invitation to outpatient clinic | DSM-IV | 21.2% | 12,558 |
| Stulhofer et al. 2005 [ | Interview | Stratified sampling | Often ejaculating in less than 2 minutes | 9.5% | 601 |
| Porst et al. 2007 (Premature Ejaculation Prevalence and Attitudes) [ | Web-based survey (self-report) | Internet panel | Control over ejaculation, distress | 22.7% | 12,133 |
| Shindel et al. 2008 [ | Questionnaire | Male partners of infertile couples under evaluation | Self report premature ejaculation | 50% | 73 |
| Brock et al. 2009 [ | Telephone interview | Web-based survey | DSM-III | 16% | 3,816 |
| Control | 26% | ||||
| Distress | 27% | ||||
| Traeen et al. 2010 [ | Mailed questionnaire and Internet | Web interview and randomization | NA | 27% | 11,746 and 1,671 |
| Son et al. 2010 [ | Questionnaire | Internet panel (≤60 years) | DSM-IV | 18.3% | 600 |
| Amidu et al. 2010 [ | Questionnaire | NA | NA | 64.7% | 255 |
| Liang et al. 2010 [ | NA | NA | ISSM | 15.3% | 1,127 |
| Park et al. 2010 [ | Mailed questionnaire | Stratified sampling | Suffering from PE | 27.5% | 2,037 |
| Vakalopoulos et al. 2010 [ | One-on-one survey | Population-based cohort | ED | 58.43% | 522 |
| Lifelong PE | 17.7% | ||||
| Hirshfeld et al. 2010 [ | Web-based survey | Online advertisement in the USA and Canada | Climaxing/ejaculating too rapidly during the past 12 months | 34% | 7,001 |
| Christensen et al. 2011 [ | Interview and questionnaire | Population register (random) | NA | 7% | 5,552 |
| Serefoglu et al. 2011 [ | Interview | Stratified sampling | Complaining about ejaculating prematurely | 20.0% | 2,593 |
| Son et al. 2011 [ | Questionnaire | Internet panel | Estimated IELT ≤5 minutes, inability to control ejaculation, distress | 10.5% | 334 |
| Tang and Khoo 2011 [ | Interview | Primary care setting | PEDT ≥9 | 40.6% | 207 |
| Mialon et al. 2012 [ | Mailed questionnaire | Convenience sampling (18–25 years old) | Control over ejaculation, distress | 11.4% | 2,507 |
| Shaeer et al. 2012 [ | Web-based survey | Online advertisement in Arabic countries | Ejaculation before the person wishes to ejaculate at least sometimes | 83.7% | 804 |
| Shindel et al. 2012 [ | Web-based survey | Online advertisement targeted to MSM and distribution of invitation to organizations catering to MSM | PEDT ≥9 | 8–12% | 1,769 |
| McMahon et al. 2012 [ | Computer-assisted interviewing, either online or in person and self-completed | NA | PEDT ≥11 | 16% | 4,997 |
| Self-reported (always/nearly-always) | 13% | ||||
| Lotti et al. 2012 [ | Interview | Men seeking medical care for infertility | PEDT ≥9 | 15.6% | 244 |
| Zhang et al. 2013 [ | Interview | Random stratified sample of married men aged 30–60 | Self-reported premature ejaculation | 4.7% | 728 |
| Lee et al. 2013 [ | Interview | Stratified random sampling | PEDT ≥11 | 11.3% | 2,081 |
| Self-reported PE | 19.5% | ||||
| IELT <1 minute | 3% | 1,035 | |||
| Shaeer 2013 [ | Web-based survey | Online advertisement in the United States | PEDT ≥11 | 50% | 1,133 |
| Self-reported any PE | 78% | ||||
| Self-reported PE “always” or “mostly” | 14% | ||||
| Gao et al. 2013 [ | Interview | Random stratified sample of monogamous heterosexual men in China | Self-reported premature ejaculation | 25.8% | 3,016 |
| Hwang et al. 2013 [ | Survey of married couples | Married heterosexual couples in Korea | Estimated IELT <2 minutes | 21.7% | 290 |
| PEDT ≥11 | 12.1% | ||||
| Vansintejan et al. 2013 [ | Web-based survey | Online and flyer advertisements to Belgian MSM (only HIV+ men in this study) | IPE score ≤50% of total possible | 4% | 72 |
| IPE score ≤66% of total possible | 18% |
NA = not applicable; MSM = men who have sex with men; PEDT = Premature Ejaculation Diagnostic Tool; IPE = Index of Premature Ejaculation
Distribution of patients with the complaint of PE according to PE syndromes in the general population and outpatient clinics in Turkey and China
| General male population | |||||
|---|---|---|---|---|---|
| Study | Population (n) | Lifelong PE (%) | Acquired PE (%) | Variable PE (%) | Subjective PE (%) |
| Serefoglu et al. 2011 [ | 2,593 | 2.3% | 3.9% | 8.5% | 5.1% |
| Gao et al. 2013 [ | 3,016 | 3.2% | 4.8% | 11.4% | 6.4% |
| Fasolo et al. 2005 [ | 2,658 | 21.4% | 69.8% | Not specified: 8.8% | |
| Serefoglu et al. 2010 [ | 261 | 62.5% | 16.1% | 14.5% | 6.9% |
| Zhang et al. 2013 [ | 1988 | 35.7% | 28.1% | 12.7% | 23.5% |
Demographic, IELT, and PRO data from the post hoc analysis of five Phase 3 dapoxetine trials
| Parameter | McMahon et al. 2013 [ | |||||||
|---|---|---|---|---|---|---|---|---|
| Overall | IIEF-EF 21–25 | IIEF-EF 25–26 | Porst et al. 2010 [ | |||||
| Acquired PE | Lifelong PE | Acquired PE | Lifelong PE | Acquired PE | Lifelong PE | Acquired PE | Lifelong PE | |
| Age (years), mean | 52.2 | 45.5 | 53.3 | 46.5 | 51 | 44.5 | 41.9 | 39.7 |
| IELT (min), mean | 1.205 | 0.99 | 1.26 | 0.99 | 1.16 | 0.99 | 1.07 | 0.9 |
| IELT <1 minute | 39.5% | 57.0% | 35% | 60% | 44% | 54% | 45% | 58% |
| IELT 1–2 minutes | 58.5% | 41.5% | 64% | 38% | 53% | 45% | 55% | 41% |
| Control | ||||||||
| Very poor | 28.0% | 47.5% | 23% | 44% | 33% | 51% | 35% | 47% |
| Very poor + poor | 80.5% | 92.5% | 81% | 93% | 80% | 92% | 90% | 94% |
| Satisfaction | ||||||||
| Very poor | 16.0% | 29.0% | 17% | 30% | 15% | 28% | 21% | 22% |
| Very poor + poor | 52.0% | 76.5% | 56% | 79% | 48% | 74% | 71% | 66% |
| Distress | ||||||||
| Quite a bit + extremely | 66.0% | 83.5% | 63% | 83% | 69% | 84% | 72% | 71% |
| Interpersonal difficulty | ||||||||
| Quite a bit + extremely | 37.0% | 58.0% | 40% | 65% | 34% | 51% | 42% | 37% |
IIEF-EF = International Index of Erectile Function erectile function domain
| Ege Can Serefoglu | Allergan, Consultant |
| Stanley Althof | Allergan—Consultant, Advisory Board, Principal Investigator |
| Abvie—Consultant | |
| Eli Lilly—Consultant | |
| Ixchelsis—Consultant | |
| Menarini—Speaker | |
| Palitan—Advisory Board | |
| Plethora—Consultant | |
| Sprout—Advisory Board, Consultant | |
| Trimel—Principal Investigator | |
| Chris McMahon | Johnson & Johnson—Consultant, Principal Investigator, Advisory Board Member, Speaker |
| Menarini Group—Principal Investigator, Advisory Board Member, Speaker | |
| Bayer Schering—Investigator, Advisory Board, Speaker | |
| Plethora Solutions—Advisory Board, Speaker | |
| Ixchelsis—Consultant | |
| Marcel Waldinger | Emotional Brain B.V—Advisory Board |
| Menarini Netherlands—Advisory Board | |
| Pound Int.—Advisory Board | |
| Alan Shindel | Elsevier, |
| International Society of Sexual Medicine, | |
| International Society for the Study of Women's Sexual Health, | |
| Sexual Medicine Society of North America, | |
| Strategic Science and Technology, LLC | |
| P. Ganesan Adaikan | Menarini—Consultant |
| Edgardo Becher | Eli Lilly—Speaker, Investigator |
| GSK—Speaker, Advisory Board | |
| Pfizer—Speaker | |
| John Dean | Plethora Pharmaceuticals—consultant or lecturer |
| The Urology Company consultant or lecturer— | |
| Shianogi Pharmaceuticals consultant or lecturer— | |
| Repros Pharmaceuticals consultant or lecturer— | |
| Emotional Brain BV (Netherlands) consultant or lecturer | |
| Spimaco (Saudi Arabia)—consultant or lecturer | |
| François Giuliano | Pfizer-Lecturer |
| Eli Lilly—Lecturer, Investigator and Consultant | |
| Menarini—Lecturer | |
| Allergan—Consultant | |
| Menarini—Consultant | |
| Sanofi—Consultant | |
| Bayer-Schering—Investigator and Consultant | |
| Johnson and Johnson—Investigator and Consultant | |
| GSK—Investigator and Consultant | |
| Wayne J.G. Hellstrom | American Medical Systems—Consultant or Advisor |
| Andromedical—Consultant or Advisor | |
| Auxilium—Meeting Participant, Lecturer, Consultant, Investigator, Advisor | |
| Allergan—Consultant or Advisor, Scientific Study or Trial | |
| Coloplast—Consultant or Advisor, Investigator | |
| Cook—Consultant or Advisor, Lecturer | |
| Endo—Consultant or Advisor, Investigator, Lecturer | |
| Johnson & Johnson—Consultant or Advisor, Meeting Participant or Lecturer, Investigator | |
| Lilly, USA—Consultant or Advisor, Lecturer; NIH—Board Member, Officer, Trustee | |
| Slate—Pharmaceutical—Lecturer, Advisor, and Investigator | |
| Theralogix—Board Member, Officer, Trustee | |
| VIVUS—Advisor/Consultant, Investigator, Lecturer | |
| Annamaria Giraldi | Eli Lilly: Speaker |
| Emotional Brain: Advisory Board | |
| Apricus Bioscience: Advisory board | |
| Sidney Glina | Principal Investigator for Lilly, Astra Zeneca |
| Speaker for Pfizer, Lilly, Bayer | |
| Advisory Board: Lilly, Besins | |
| Luca Incrocci | No conflicts to report |
| Emmanuele Jannini | Bayer—Consultant, Speaker, Investigator |
| Besins—Consultant, Speaker, Investigator | |
| Lilly—Consultant, Speaker, Investigator | |
| Menarini—Consultant, Speaker, Investigator | |
| Pfizer—Consultant, Speaker, Investigator | |
| Marita McCabe | Menarini—Advisory Board |
| Sharon Parish | Emotional Brain—Advisory Board |
| Shinogi—Advisory Board | |
| Apricus—Advisory Board | |
| Strategic Science and Technology—Advisory Board | |
| Pfizer—Advisory Board | |
| David Rowland | No conflicts to report |
| Robert Segraves | Advisor and Investor S1Biopharm |
| Ira Sharlip | Speaker and consultant to Pfizer and Lilly; Consultant to Absorption Pharmaceuticals and Plethora |
| Luiz Otavio Torres | Speaker for Bayer, Janssen, Lilly, Pfizer, GSK. |
| Member of the advisory board for Lilly |